The most common acquired resistance mechanism to EGFR‐TKIs is a T7920M secondary mutation of the EGFR gene in cis‐position, as it accounts for ~50% of all TKI‐resistant lung cancer cases 6. The gene discussed is EGFR; the disease is lung cancer.